Funder
Fellowship from the Agency for Business Competitiveness of the Government of Catalonia.
Publisher
Springer Science and Business Media LLC
Reference61 articles.
1. Mendis, S., Puska, P. & Norrving, B. Global Atlas On Cardiovascular Disease Prevention And Control. (ed. Mendis, S., Puska, P. & Norrving, B.) 1–164 (Geneva: World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization, 2011).
2. Millan Nuñez-Cortes, J. et al. Documento Abordaje de la dislipidemia. Sociedad Española deArteriosclerosis (parte III). Clin. e Investig. en Arterioscler. 24, 102–107 (2012).
3. Sharma, K. & Baliga, R. R. Genetics of Dyslipidemia and Ischemic Heart Disease. Curr. Cardiol. Rep. 19, 46 (2017).
4. Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (London, England) 364, 937–52 (2004).
5. De la Sierra, A. et al. Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain. Adv. Ther. 32, 944–61 (2015).
Cited by
132 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献